Start with the primary record
FDA notices, trial registrations, labels, journal papers, and laboratory records come before commentary.
COMPOUND IQRESEARCH. TESTED. EXPLAINED.Scan a COAPEPTIDE NEWS · SOURCE FIRST
The headline is the start of the review.
Timely analysis of peptide regulation, testing, and clinical evidence. Every article separates what a primary source establishes from what the internet turns it into.
Regulatory watch6 min read
FDA warned five peptide sellers in one day. Here’s what the letters actually say.
The newest FDA letters focus on marketing claims and intended use—not laboratory proof that every cited vial was impure.
Read the analysisTHE NEWS STANDARD
Fast enough to matter. Careful enough to trust.
Compound IQ news follows the same evidence discipline used in our COA reviews.
Separate different questions
Analytical quality, clinical evidence, and regulatory status are related—but they are not interchangeable.
Show what did not happen
Every story identifies the conclusions a source supports and the conclusions it does not.